Marina Vaysburd
0000-0001-7236-678X
MRC Centre
2 papers found
Refreshing results…
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery
Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice
Missing publications? Search for publications with a matching author name.